Akoya Biosciences unveils new era in spatial content innovation

Akoya Biosciences (AKYA) will unveil innovations designed to accelerate insights in immuno-oncology, IO, and advance preclinical research at the Society for Immunotherapy of Cancer, SITC, 2024 Annual Meeting. The company will present its latest offerings, including the groundbreaking ultrahigh-plex PhenoCode Discovery IO60 panel encompassing 60 tumor and immunology markers and a panel for spatial phenotyping of murine cancer models in preclinical studies. The new 60-biomarker IO60 Panel addresses the growing need for a comprehensive IO panel that includes an extensive set of fully validated markers. Akoya is also introducing a 24-biomarker mouse formalin-fixed paraffin-embedded IO antibody panel for single-cell spatial phenotyping of key immune cell types in the tumor microenvironment. Driven by a transformative vision to make ultrahigh-plex spatial biology accessible to all, Akoya is expanding its PhenoCode catalog of molecular barcodes